Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2021

Nov 10, 2021

SELL
$27.35 - $37.28 $292,645 - $398,896
-10,700 Closed
0 $0
Q2 2021

Aug 11, 2021

BUY
$26.5 - $38.23 $283,550 - $409,060
10,700 New
10,700 $7,000
Q1 2021

May 14, 2021

SELL
$29.83 - $56.81 $4.72 Million - $8.99 Million
-158,300 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$39.12 - $54.99 $6.19 Million - $8.7 Million
158,300 New
158,300 $235,000

Others Institutions Holding ZYME

About Zymeworks Inc.


  • Ticker ZYME
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 61,694,400
  • Market Cap $949M
  • Description
  • Zymeworks Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer. The company's lead product candidates include zanidatamab, a novel bispecific antibody that is in Phase 1 and Phase 2 clinical trials for the treatment of biliary tract, gastroesophageal adenocarcinomas...
More about ZYME
Track This Portfolio

Track Hap Trading, LLC Portfolio

Follow Hap Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hap Trading, LLC with notifications on news.